Advertisement

The Scientist

» stem cells

Most Recent

image: STAP Papers Retracted

STAP Papers Retracted

By | July 2, 2014

Nature issues retractions of the stimulus-triggered acquisition of pluripotency papers and pens an editorial on the controversy surrounding their publication.

0 Comments

image: Banking on iPSCs

Banking on iPSCs

By | June 30, 2014

A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: Week in Review: June 9–13

Week in Review: June 9–13

By | June 13, 2014

Ancient apoptotic pathway connects humans to coral; lab-grown, light-sensing retinal tissue; tracking cancer with synthetic phospholipids; diving deep into the lung microbiome

0 Comments

image: Light-Sensing Retina in a Dish

Light-Sensing Retina in a Dish

By | June 10, 2014

From human induced pluripotent stem cells, researchers grow 3-D retinal tissue that can sense light. 

0 Comments

image: Week in Review: June 2–6

Week in Review: June 2–6

By | June 6, 2014

The malnourished microbiome; innate immunity and beige fat; tools for stem cell self-renewal; predicting tomorrow’s PIs; MERS update

0 Comments

image: Minimal Toolkit for Stem Cell Self-Renewal

Minimal Toolkit for Stem Cell Self-Renewal

By | June 5, 2014

Researchers identify a network of a dozen transcription factors needed to maintain the pluripotent state of mouse embryonic stem cells. 

0 Comments

image: Final Straw for STAP?

Final Straw for STAP?

By | June 4, 2014

Independent analysis uncovers suspected mouse cell mix-up, while stimulus-triggered acquisition of pluripotency lead author Haruko Obokata agrees to retract the work in full.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Four-legged Snake Fossil Found
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
PDA
PDA
Advertisement